Schroder Investment Management Group Sells Illumina Shares

Institutional investor reduces stake in life sciences company

Mar. 12, 2026 at 10:10am

Got story updates? Submit your updates here. ›

Schroder Investment Management Group decreased its holdings in Illumina, Inc. (NASDAQ:ILMN) by 15.0% in the third quarter, according to a disclosure with the Securities & Exchange Commission. The institutional investor owned 374,025 shares of the life sciences company's stock after selling 66,235 shares during the period.

Why it matters

Illumina is a leading provider of genetic sequencing technology, and changes in institutional ownership can signal shifts in investor sentiment around the company's prospects. This sale by Schroder Investment Management Group may indicate broader market concerns about Illumina's performance or outlook.

The details

According to the filing, Schroder Investment Management Group sold 66,235 shares of Illumina, reducing its total stake to 374,025 shares. The institutional investor owned about 0.24% of Illumina's outstanding shares as of the most recent filing.

  • Schroder Investment Management Group decreased its Illumina holdings in the third quarter of 2026.

The players

Schroder Investment Management Group

An institutional investor that manages assets on behalf of clients.

Illumina, Inc.

A leading life sciences company that develops and markets genetic sequencing technology and tools.

Got photos? Submit your photos here. ›

The takeaway

This sale by a major institutional investor could signal broader concerns about Illumina's performance and outlook, though the reasons behind the decision are not fully clear. Investors will likely watch for any further changes in institutional ownership and analyst sentiment around the company.